7-phenylpyrazolopyridine compounds

Details 7-phenylpyrazolopyridine compounds 7-phenylpyrazolopyridine compounds

2008-01-29

2008-01-29

Seaman, Margaret D. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07323569

ABSTRACT:
A compound represented by the formula:[wherein R1is methoxy, methylthio, ethyl, etc.; R5and R6are each independently cyclopropylmethyl, (4-tetrahydropyranyl)methyl, etc.; and two of R40, R41and R42are C1-6alkoxy while the remaining one is methoxymethyl, etc.], a salt thereof, or a hydrate of the foregoing. This compound has excellent antagonism against corticotropin-releasing factor receptor.

REFERENCES:
patent: 4925849 (1990-05-01), Shiokawa et al.
patent: 4990516 (1991-02-01), Ohashi et al.
patent: 5338743 (1994-08-01), Shiokawa et al.
patent: 5445943 (1995-08-01), Hoenes
patent: 5457200 (1995-10-01), Zimmermann et al.
patent: 5565468 (1996-10-01), Larsen et al.
patent: 5691347 (1997-11-01), Corbier et al.
patent: 7091215 (2006-08-01), Hibi et al.
patent: 7151109 (2006-12-01), Fu
patent: 7176216 (2007-02-01), Hibi et al.
patent: 0 433 853 (1991-06-01), None
patent: 0 433 854 (1991-06-01), None
patent: 0 611 766 (1994-08-01), None
patent: 0 659 747 (1995-06-01), None
patent: 0812831 (1997-12-01), None
patent: 2001-89368 (2001-04-01), None
patent: WO-94/13643 (1994-06-01), None
patent: WO-94/13644 (1994-06-01), None
patent: WO-94/13661 (1994-06-01), None
patent: WO-94/13676 (1994-06-01), None
patent: WO-94/13677 (1994-06-01), None
patent: WO-95/10506 (1995-04-01), None
patent: WO-95/34563 (1995-12-01), None
patent: WO-97/29109 (1997-08-01), None
patent: WO-97/29110 (1997-08-01), None
patent: WO-98/08847 (1998-03-01), None
patent: WO-98/35967 (1998-08-01), None
patent: WO-99/01454 (1999-01-01), None
patent: WO-99/10350 (1999-03-01), None
patent: WO-00/01697 (2000-01-01), None
patent: WO-00/39127 (2000-07-01), None
patent: WO-00/59907 (2000-10-01), None
patent: WO-00/59908 (2000-10-01), None
patent: WO-01/35917 (2001-05-01), None
patent: WO-01/44248 (2001-06-01), None
patent: WO-02/06286 (2002-01-01), None
patent: WO-02/058704 (2002-08-01), None
patent: WO-02/18320 (2002-09-01), None
patent: WO-02/088121 (2002-11-01), None
patent: WO-03/072536 (2003-09-01), None
patent: WO-03/078435 (2003-09-01), None
Hiroi et al., Molecular Psychiatry, “Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls”, 2001, vol. 6, pp. 540-546.
Sauvage et al., Neuroscience, “Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine nasal forebrain and brainstem nuclei-potential implication for arousal and attention”, vol. 104, pp. 643-652.
Vale et al., Science, vol. 213, pp. 1394-1397, (1981).
Rivier et al., Proc. Natl. Acad. Sci, vol. 80, pp. 4851-4855, (1983).
Shibahara et al., EMBO Journal, vol. 2, No. 5, pp. 775-779, (1983).
Dieterich et al., Exp. Clin. Endocrinol. Diabetes, vol. 105, pp. 65-82, (1997).
Vale et al., Recent Progress in Hormone Research, vol. 39, pp. 245-270, (1983).
Dunn et al., Brain Research Reviews, vol. 15, pp. 71-100, (1990).
Owens et al., Pharmacol. Reviews, vol. 43, No. 4, pp. 425-473, (1991).
Arborelius et al., J. of Endocrinology, vol. 160, pp. 1-12, (1999).
Kalin et al., Brain Research, vol. 509, pp. 80-84, (1990).
Tazi et al., Regulatory Peptides, vol. 18, pp. 37-42, (1987).
Stenzel-Poore et al., J. of Neuroscience, vol. 14, No. 5, pp. 2579-2584, (1994).
Baldwin et al., Psychopharmacology, vol. 103, pp. 227-232, (1991).
Sirinathsinghji et al., Nature, vol. 305, pp. 232-235, (1983).
Sherman et al., Pharm. Bio. & Behavior, vol. 26, pp. 699-703, (1987).
Chalmers et al.; TIPS, vol. 17, pp. 166-172, (1996).
Ehlers et al., Brain Research, vol. 278, pp. 332-336, (1983).
Banki et al., Am. J. Psychiatry, vol. 144, No. 7, pp. 873-877, (1987).
Whitehouse et al., Neurology, vol. 37, pp. 905-909, (1987).
De Souza et al., Brain Research, vol. 437, pp. 355-359, (1987).
Stenzel-Poore et al., Endocrinology, vol. 130, No. 6, pp. 3378-3386, (1992).
Krahn et al., Brain Research Bulletin, vol. 17, pp. 285-289, (1986).
Taché et al., Annals of the New York Academy of Sciences, vol. 697, pp. 233-243, (1993).
Barquist et al., American Physiological Society, pp. G616-G620, (1992).
Gunion et al., American Physiological Society, pp. G152-G157, (1990).
Bakke et al., Life Sciences, vol. 45, pp. 907-916, (1989).
Lenz et al., Gastroenterology, vol. 95, pp. 1510-1517, (1988).
Ford et al., Gastroenterology, vol. 109, pp. 1772-1780, (1995).
Lembo et al., Neurogastroenterol. Mot., vol. 8, pp. 9-18, (1996).
Fukudo et al., Gut, vol. 42, pp. 845-849, (1998).
Morimoto et al., J. of Physiology, vol. 460, pp. 221-229, (1993).
Theoharides et al., Endocrinology, vol. 139, No. 1, pp. 403-413, (1998).
Scopa et al., Am. J. of Pathology, vol. 145, No. 5, pp. 1159-1167, (1994).
Poliak et al., Journal of Immunology, vol. 158, pp. 5751-5756, (1997).
Murakami et al., Endocrine Journal, vol. 44, No. 4, pp. 627-629, (1997).
Singh et al., Journal of Neuroimmunology, vol. 23, pp. 257-262, (1989).
Singh et al., Neuroscience Letters, vol. 120, pp. 151-154, (1990).
Jain et al., Endocrinology, vol. 128, No. 3, pp. 1329-1336, (1991).
Böhmer et al., European Journal of Pharmacology, vol. 182, pp. 405-411, (1990).
Nink et al., Acta Endocrinologica, vol. 127, pp. 200-204, (1992).
Rivier et al., Science, vol. 224, pp. 889-891, (1984).
Menzaghi et al., J. of Pharm. & Exp. Therapeautics, vol. 269, No. 2, pp. 564-572, (1994).
Sasaki et al., J. of Clin. End. And Metab., vol. 65, No. 1, pp. 176-182, (1987).
Sasaki et al., J. of Clin. End. And Metab., vol. 67, No. 4, pp. 768-773, (1988).
Garrick et al., Reg. Peptides, vol. 21, pp. 173-181, (1988).
Petrusz et al., Peptides, vol. 5, Sup. 1, pp. 71-78, (1984).
Chalmers et al., J. of Neuro., vol. 15, No. 10, pp. 6340-6350, (1995).
Liaw et al., Endocrinology, vol. 137, No. 1, pp. 72-77, (1996).
Valdenaire et al., BBA, vol. 1352, pp. 129-132, (1997).
Vale et al., Recent Prog. Horm. Res., vol. 39, pp. 245-270, (1983).
Raadsheer et al., Am. J. Psychiatry, vol. 152, No. 9, pp. 1372-1376, (1995).
Nemeroff et al., Arch. Gen. Psychiatry, vol. 45, pp. 577-579, (1988).
Gold et al., N. Engl. J. Med., vol. 314, No. 21, pp. 1329-1335, (1986).
Altemus et al., Arch. Gen. Psychiatry, vol. 51, pp. 794-803, (1994).
Bremner et al., Am. J. Psychiatry, vol. 154, No. 5, pp. 624-629, (1997).
Chappell et al., Biol. Psychiatry, vol. 39, pp. 776-783, (1996).
Roy-Byrne et al., Am J. Psychiatry, vol. 143, No. 7, pp. 896-899, (1986).
Monnikes et al., Brain Research, vol. 574, pp. 70-76, (1992).
Butler et al., J. of Neuroscience, vol. 10, No. 1, pp. 176-183, (1990).
Owens et al., J. of Pharm. And Exp. Ther., vol. 258, No. 1, pp. 349-356, (1991).
Lyons et al., Brain Research, vol. 545, pp. 339-342, (1991).
Strijbos et al., Brain Research, vol. 656, pp. 405-408, (1994).
Behan et al., Nature, vol. 378, pp. 284-287, (1995).
Diamant et al., Neuroendocrinology, vol. 57, pp. 1071-1081, (1993).
Hotta et al., J. Clin. Endocrinology, vol. 62, No. 2, pp. 319-324, (1986).
Levine et al., Neuropharmacology, vol. 22, No. 3A, pp. 337-339, (1983).
Arase et al., Physiology & Behavior, vol. 45, pp. 565-570, (1989).
Plotsky et al., Endocrinology, vol. 130, No. 4, pp. 1931-1941, (1992).
Nicholson et al., Regulatory Peptides, vol. 18, pp. 173-188, (1987).
Tache et al., Am. J. Physiol., vol. 253, pp. G241-G245, (1987).
Karlais et al., Science, vol. 254, pp. 421-423, (1991).
Crofford et al., J. Clin. Invest., vol. 90, pp. 2555-2564, (1992).
Crofford et al., J. of Immun., vol. 151, No. 3, pp. 1587-1596, (1993).
Singh et al., J. Pharmacol. Exp. Ther., vol. 288, No. 3, pp. 1349-1356, (1999).
Whitten et al., J. Med. Chem. 1996, 39, 4354-4357.
Chen et al., J. Med. Chem. 1996, 39, 4358-4360.

Affiliated with

Also associated with

Rating

7-phenylpyrazolopyridine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 7-phenylpyrazolopyridine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-phenylpyrazolopyridine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2777049